On 19th November 2019, Renalytix AI participated at the well-attended Kidney Health capital market day led by the American Society of Nephrology (ASN) in London. The event focused on the problems and opportunities arising from kidney health and disease, and brought together a remarkable group of delegates representing the broad kidney community, including leading clinicians, representatives of US governmental bodies and business leaders. The clear takeaway from yesterday was the huge exciteme
20 Nov 2019
Kidney Capital Markets day – a positive shift in Kidney health
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Kidney Capital Markets day – a positive shift in Kidney health
Renalytix Plc (RENX:LON) | 26.5 0 0.0% | Mkt Cap: 33.4m
- Published:
20 Nov 2019 -
Author:
Edward Thomason -
Pages:
4
On 19th November 2019, Renalytix AI participated at the well-attended Kidney Health capital market day led by the American Society of Nephrology (ASN) in London. The event focused on the problems and opportunities arising from kidney health and disease, and brought together a remarkable group of delegates representing the broad kidney community, including leading clinicians, representatives of US governmental bodies and business leaders. The clear takeaway from yesterday was the huge exciteme